Systemic Inflammation and Lung Function Impairment in Morbidly Obese Subjects with the Metabolic Syndrome
Table 2
Comparison of blood parameters between subjects with and without metabolic syndrome.
No metabolic syndrome ()
Metabolic syndrome ()
value
Leukocytes (109/L)
8.6 ± 2.3
8.9 ± 2.1
0.2531
Neutrophils (%)
70.1 ± 8.6
68.9 ± 9.1
0.186
Lymphocytes (%)
23.7 ± 7.1
23.8 ± 7.0
0.844
Monocytes (%)
4.9 ± 1.8
5.3 ± 1.9
0.044
Eosinophils (%)
0.82 (0.05–1.07)
1.00 (0.45–1.85)
0.0022
CRP (mg/L)3
9.6 ± 7.4
9.5 ± 8.0
0.865
Cholesterol (mmol/L)
5.2 ± 1.0
5.1 ± 1.1
0.198
HDL-cholesterol (mmol/L)
1.3 ± 0.3
1.1 ± 0.2
<0.001
LDL-cholesterol (mmol/L)
3.5 ± 0.9
3.3 ± 1.1
0.108
Triglyceride (mmol/L)
1.0 ± 0.4
1.6 ± 1.0
<0.001
Glucose (mmol/L)
6.3 ± 1.3
8.2 ± 3.9
<0.001
HbA1C (%)
5.52 ± 0.4
6.4 ± 1.5
<0.001
Insulin (mE/L)3
56.2 ± 58.1
75.0 ± 79.4
<0.001
Vitamin D (nmol/L)
39.5 ± 22.9
38.5 ± 17.7
0.661
IgE (kU/L)3
213.5 ± 479.9
197.8 ± 391.3
0.141
Positive inhalation screen
46.2%
44.0%
0.694
1Data presented as mean ± standard deviation, value for Student’s -test.
2Data presented as median (1st–3rd quartiles), value for Mann-Whitney test.
3Data were log transformed for statistical analysis.
